Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Solesence (SLSN) Other Non-Current Liabilities (2016 - 2025)

Solesence's Other Non-Current Liabilities history spans 16 years, with the latest figure at $194000.0 for Q4 2025.

  • For Q4 2025, Other Non-Current Liabilities fell 21.14% year-over-year to $194000.0; the TTM value through Dec 2025 reached $194000.0, down 21.14%, while the annual FY2025 figure was $194000.0, 21.14% down from the prior year.
  • Other Non-Current Liabilities reached $194000.0 in Q4 2025 per SLSN's latest filing, down from $252000.0 in the prior quarter.
  • In the past five years, Other Non-Current Liabilities ranged from a high of $252000.0 in Q3 2025 to a low of $194000.0 in Q4 2025.
  • Average Other Non-Current Liabilities over 5 years is $232050.0, with a median of $233000.0 recorded in 2023.
  • Peak YoY movement for Other Non-Current Liabilities: grew 4.13% in 2022, then dropped 21.14% in 2025.
  • A 5-year view of Other Non-Current Liabilities shows it stood at $222000.0 in 2021, then grew by 3.6% to $230000.0 in 2022, then rose by 3.48% to $238000.0 in 2023, then increased by 3.36% to $246000.0 in 2024, then decreased by 21.14% to $194000.0 in 2025.
  • Per Business Quant, the three most recent readings for SLSN's Other Non-Current Liabilities are $194000.0 (Q4 2025), $252000.0 (Q3 2025), and $250000.0 (Q2 2025).